IN-C005
/ Korea Kolmar
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 16, 2022
Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians
(clinicaltrials.gov)
- P1 | N=20 | Completed | Sponsor: HK inno.N Corporation | Not yet recruiting ➔ Completed | Trial completion date: May 2022 ➔ Nov 2021
Trial completion • Trial completion date
August 13, 2021
Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians
(clinicaltrials.gov)
- P1; N=20; Not yet recruiting; Sponsor: HK inno.N Corporation
New P1 trial
1 to 2
Of
2
Go to page
1